Assessing the immunogenicity risk of salmon calcitonin peptide impurities using in silico and in vitro methods

08-2024

Poster: Immunogenicity Risk Assessment of Salmon Calcitonin Peptide Impurities Using In Silico and In Vitro Methods

05-2024

Poster: Rapid and Predictive Immunogenicity Risk Assessments Using In Silico Methods

05-2024

Poster: Comprehensive assessment of immunogenicity risk of host cell proteins in biologics and vaccines using in silico and in vitro methods

05-2024

Poster: An “I” (Immunogenicity Risk Assessment) for an Eye (Ophthalmology Biologics)

05-2024

Individual and population-level variability in HLA-DR associated immunogenicity risk of biologics used for the treatment of rheumatoid arthritis

05-2024

In silico methods for immunogenicity risk assessment and human homology screening for therapeutic antibodies

04-2024

Neoadjuvant personalized cancer vaccines: the final frontier?

01-2024

A SARS-CoV-2 NSP7 homolog of a Treg epitope suppresses CD4+ and CD8+ T cell memory responses

11-2023

Development of IFNβ-1a versions with reduced immunogenicity and full in vitro biological activity for the treatment of multiple sclerosis

11-2023

Does human homology reduce the potential immunogenicity of non-antibody scaffolds?

10-2023

Poster: iVAX for antigen discovery, vaccine design, diagnostics, and epidemiology

09-2023